technologyJul 9, 202531:40pending

How Bristol Myers Squibb Is Accelerating Drug Development With AI - Ep. 264

About this episode

Greg Meyers, chief digital and technology officer at Bristol Myers Squibb, explains how AI is transforming pharmaceutical research from hypothesis-driven hunches to data-driven discoveries. Learn how the company is using computational chemistry to engineer breakthrough therapies like a sickle cell treatment heading to human trials, and why they built internal AI tools for 25,000+ employees. Learn more at ai-podcast.nvidia.com.

Get every episode summarized

Each time NVIDIA AI Podcast publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

Hosts & guests

NVIDIAHost

No transcript yet

This episode has not been transcribed. Request it and it moves to the front of the queue.

More episodes

How Bristol Myers Squibb Is Accelerating Drug Development With AI - Ep. 264

About this episode

Get every episode summarized

Hosts & guests

More from NVIDIA AI Podcast

How AI Will Change Quantum Computing - Ep. 294

Building AI Factories: How Red Hat and NVIDIA Turn Enterprise Data Into Intellig...

Powering the AI Inference Wave with EPRI's Ben Sooter - Ep. 292

AI Agents and the Future of Global Trade with Alibaba’s Kuo Zhang - Ep. 291